Original Pharmacy Stalwart, Redcare, Faces Sale After Decades in Business
Let's Talk Stocks: Redcare Pharmacy's Ride
In the freestyle format of Chartzeit, it's all about you and your stock of choice. Today, we're diving into Redcare Pharmacy, a popular pick among viewers' comments and the Mahlzeit show.
| Settings | Current Price | Performance (1Y) | Chart (1Y) | Settings |Redcare Pharmacy Chart
- 06.05.24 - 06.05.25
- 1T
- 1W
- 1M
- 1Y
- 3Y
- max
|To the Detailed Page To the Chart Analysis
There's no denying it, Redcare Pharmacy's model portfolio stock didn't disappoint with its Q1 2025 results. The stock saw an initial jump of over 2% following the earnings report. But then, things took a turn — the stock plummeted more than 10% within mere hours.
Redcare Pharmacy
Xetra · |The momentum has now shifted back in a downward direction, making it less favorable for long positions. What's next? Should you toss in the towel or hang tight? Martin Goersch spills the beans in today's video.
Xetra ·
|| Settings | Current Price | Performance (1Y) | Chart (1Y) | Settings || --- | --- | --- | --- | --- || Redcare Pharmacy | Xetra · | | ChartLine chart with 53 data points.Chart for Redcare PharmacyThe chart has 1 X axis displaying Time. Data ranges from 2024-05-06 00:00:00 to 2025-05-06 14:00:00.The chart has 1 Y axis displaying values. Data ranges from 98 to 162.7.Loading...End of interactive chart. || Redcare Pharmacy (ADR) | Nasdaq OTC · | | ChartLine chart with 34 data points.Chart for Redcare Pharmacy (ADR)The chart has 1 X axis displaying Time. Data ranges from 2024-05-13 14:00:00 to 2025-04-25 14:00:00.The chart has 1 Y axis displaying values. Data ranges from 10.91 to 17.94.Loading...End of interactive chart. |
ChartLine chart with 53 data points.Chart für Redcare PharmacyThe chart has 1 X axis displaying Time. Data ranges from 2024-05-06 00:00:00 to 2025-05-06 14:00:00.The chart has 1 Y axis displaying values. Data ranges from 98 to 162.7.Lade...End of interactive chart. |### Premium Articles on our Website
Chart
Line chart with 53 data points.Chart für Redcare PharmacyThe chart has 1 X axis displaying Time. Data ranges from 2024-05-06 00:00:00 to 2025-05-06 14:00:00.The chart has 1 Y axis displaying values. Data ranges from 98 to 162.7.Lade...End of interactive chart.
| ChartLine chart with 34 data points.Chart für Redcare Pharmacy (ADR)The chart has 1 X axis displaying Time. Data ranges from 2024-05-13 14:00:00 to 2025-04-25 14:00:00.The chart has 1 Y axis displaying values. Data ranges from 10.91 to 17.94.Lade...End of interactive chart. |Stocks on the Drop: Which DAX Stocks are Primed for a Pullback? Retail Investors are Crazy for US Stocks — Can the Recovery Rally Continue? Recession or Ilusion? Understanding the US's Economic Climate More Articles
Redcare Pharmacy (ADR) ### You might also be interested in
Chart
Line chart with 34 data points.Chart für Redcare Pharmacy (ADR)The chart has 1 X axis displaying Time. Data ranges from 2024-05-13 14:00:00 to 2025-04-25 14:00:00.The chart has 1 Y axis displaying values. Data ranges from 10.91 to 17.94.Lade...End of interactive chart.
Nasdaq OTC · |Netflix: Hype Turns to Fear — What Comes Next? SoFi: Transformation or Turmoil? Hims & Hers: Growth Continues — but is Palantir and Elmos Feeling the Heat? Palantir: The Slump is Over — Where's the Rebound? ▶ Shell: The BP Acquisition — What's on the Line? More Articles
Redcare Pharmacy (ADR)
|
Nasdaq OTC ·
Insights: Redcare Pharmacy's Q1 2025 results revealed sales growth of 28%, driven by strength in both the DACH (Germany, Austria, Switzerland) and international segments. Prescription sales in Germany skyrocketed by 191%, contributing significantly to overall growth. However, the company reported a net loss despite these impressive top-line figures. Redcare reaffirmed its full-year outlook, targeting sales growth in excess of 25% and mid- to long-term adjusted EBITDA margins above 8%. The company's rapid growth and expanding customer base continue to establish it as a market leader in the European e-pharmacy sector.
- Martin Goersch, in the video for the current installment of Let's Talk Stocks, has analyzed Redcare Pharmacy, a popular stock among Chartzeit viewers and the Mahlzeit show.
- After a promising initial jump of over 2% following Q1 2025 results, Redcare Pharmacy's stock plummeted more than 10% within hours, shifting momentum in a downward direction, making it less favorable for long positions.
- In finance, Redcare Pharmacy's stock can be found on the Xetra market, with an interactive chart available for detailed analysis on the Chartzeit website.
- Despite Q1 2025's sales growth of 28%, Redcare Pharmacy reported a net loss, reaffirming its full-year outlook, targeting sales growth in excess of 25% and mid- to long-term adjusted EBITDA margins above 8%.

